ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Post-doctoral Computational Chemist, Advanced Molecular Design at Eli Lilly and Company - ApplyBlast

Post-doctoral Computational Chemist, Advanced Molecular Design

Eli Lilly and Company

4 months ago

4.0 on Glassdoor

United States

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

A Post-doctoral Computational Chemist at Eli Lilly is essential for advancing structure-based drug design within the Advanced Molecular Design team. This role involves executing advanced quantum mechanics and molecular dynamics simulations to study protein interactions and accelerate the discovery of new medicines. The incumbent will build computational infrastructure, automate workflows using Python, and collaborate with multidisciplinary scientists to transition portfolio molecules into clinical candidates.

Responsibilities

Execute advanced quantum mechanical and molecular dynamics simulations
Build informatic infrastructure for computational drug discovery projects
Script and automate workflows across computational software platforms
Develop deep knowledge of computational chemistry suites like Gaussian and Orca
Collaborate with medicinal chemists and structural biologists to advance molecules

Skills

Qualifications

Ph.D. in Computational ChemistryPh.D. in Computer SciencePh.D. in CheminformaticsPh.D. in BioinformaticsPh.D. in Biophysics

About Eli Lilly and Company

lilly.com

Headquarters

Indianapolis, Indiana, United States

Company Size

10001+ employees

Founded

1876

View Profile

Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.